We also found that the expression of FLAD1 in breast cancer is associated with the expression of genes involved in metabolic processes, including NLN, UFC1, and UCHL5. Among these, UCHL5 is reversibly recruited and activated by the 19 S proteasome and shows potential as a novel target for anticancer therapy [48]. This evidence concerns the gene NLN and breast carcinoma.